Peripheral Neuropathies
Peripheral neuropathies: supportive measures and rehabilitation
Mar. 16, 2024
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
The typical clinical manifestations by organ type that have been reported in cases of Farber disease and spinal muscular atrophy with progressive myoclonic epilepsy in the published literature. Farber disease symptoms are organized by neurologic symptoms, ophthalmic symptoms, cardinal triad symptoms, respiratory symptoms, hematopoietic symptoms, gastrointestinal involvement, dermatological manifestations, liver disease, motor neuron and muscle weakness, and bone disease phenotypes.
Abbreviations: CNS - central nervous system; EMG - electromyography; FD - Farber disease; JIA - juvenile idiopathic arthritis; PNS - peripheral nervous system; SMA-PME - spinal muscular atrophy with progressive myoclonic epilepsy; and SNPs - single nucleotide polymorphisms.
(Source: Yu FP, Amintas S, Levade T, Medin JA. Acid ceramidase deficiency: Farber disease and SMA-PME. Orphanet J Rare Dis 2018;13(1):121. Creative Commons Attribution 4.0 International License. http://creativecommons.org/licenses/by/4.0.)